Safety and efficacy of AGN 203818 for pain associated with fibromyalgia syndrome
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2012
At a glance
- Drugs Rezatomidine (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 19 Jan 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 May 2011 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified February 2009).
- 23 Feb 2009 Planned end date changed from Jan 2010 to Apr 2010 as reported by ClinicalTrials.gov.